Spearhead Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$996K Sell
4,417
-33,477
-88% -$8.11M 1.08% 29
2022
Q2
$9.22M Sell
37,894
-7,833
-17% -$1.92M 1.38% 28
2022
Q1
$11.1M Buy
45,727
+2,514
+6% +$578K 1.37% 23
2021
Q4
$9.72M Buy
43,213
+1,238
+3% +$261K 1.17% 40
2021
Q3
$8.93M Buy
41,975
+6,160
+17% +$1.42M 1.19% 40
2021
Q2
$8.73M Buy
35,815
+621
+2% +$153K 1.19% 40
2021
Q1
$8.76M Buy
35,194
+8,212
+30% +$1.96M 1.29% 28
2020
Q4
$6.2M Buy
26,982
+808
+3% +$186K 0.99% 49
2020
Q3
$6.65M Buy
26,174
+1,985
+8% +$492K 1.27% 24
2020
Q2
$5.71M Sell
24,189
-750
-3% -$171K 1.22% 29
2020
Q1
$5.06M Buy
24,939
+2,215
+10% +$484K 1.46% 20
2019
Q4
$5.48M Buy
22,724
+1,227
+6% +$270K 1.36% 19
2019
Q3
$4.16M Buy
21,497
+20
+0.1% +$3.84K 1.16% 52
2019
Q2
$3.96M Buy
21,477
+1,788
+9% +$320K 1.16% 49
2019
Q1
$3.74M Buy
19,689
+788
+4% +$150K 1.13% 47
2018
Q4
$3.68M Sell
18,901
-435
-2% -$84.9K 1.58% 15
2018
Q3
$3.98M Buy
19,336
+295
+2% +$58.1K 1.33% 20
2018
Q2
$3.52M Buy
19,041
+1,108
+6% +$196K 1.26% 22
2018
Q1
$3.06M Buy
17,933
+11,994
+202% +$2.2M 1.19% 38
2017
Q4
$1.03M Buy
+5,939
New +$1.05M 0.5% 52

Other funds holding AMGN

Spearhead Capital Advisors's AMGN Position: Q3 2022 in Review

Spearhead Capital Advisors reduced its Amgen (AMGN) stake by 88% in Q3 2022, selling an estimated $8.11M and leaving 4,417 shares worth $996K. The position accounts for 1.08% of the portfolio, ranked #29.

Spearhead Capital Advisors first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $11.1M in Q1 2022. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Spearhead Capital Advisors held 4,417 shares of Amgen worth $996K as of Q3 2022.
  • Spearhead Capital Advisors sold 33,477 Amgen shares in Q3 2022, an estimated $8.11M.
  • Amgen made up 1.08% of Spearhead Capital Advisors's portfolio in Q3 2022, its #29 holding.
  • Spearhead Capital Advisors first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
  • Spearhead Capital Advisors's Amgen position peaked at $11.1M in Q1 2022.
  • 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.